Biogen Inc. buy BMO Capital Markets
Start price
14.02.24
/
50%
€206.60
Target price
14.02.25
€265.53
Performance (%)
-35.26%
End price
15.02.25
€133.75
Summary
This prediction ended on 15.02.25 with a price of €133.75. Massive losses of -35.26% were the result for the BUY prediction by BMO_Capital_Markets. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -1.450% | -1.450% | 24.174% |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $295.00 to $285.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten